Share Name Share Symbol Market Type Share ISIN Share Description
Cello Group LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 135.00p 134.00p 136.00p 135.00p 135.00p 135.00p 10,705 07:53:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.3 -1.7 -3.2 - 141.65

Cello Share Discussion Threads

Showing 976 to 999 of 1000 messages
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
DateSubjectAuthorDiscuss
18/7/2017
11:31
FinnCap; Cello has announced the acquisition of Advantage Healthcare Inc. for an initial consideration of $1.5m cash. Deferred consideration of up to $3.0m will also be paid dependent on financial performance to June 2021. Advantage (founded 20 years ago) provides critical analysis and insights in biopharmaceuticals supporting new products and business development. It will complement Cello Health's existing capabilities in consulting, market research and science-based communications and will add further depth to it's ability to work from the early stages of drug development and across the life cycle. Advantage reported sales of $4.5m in 2016 and operating profit of $0.3m. We will reassess our forecasts with tomorrows trading statement and note that given our forecast of £5m net cash at December 2017 there is scope for further bolt-ons that strengthen the offering and growth prospects.
davebowler
03/7/2017
10:04
and now rebounding firmly it would seem....DYOR
qs99
07/6/2017
07:20
Agreed, I believe there is some portfolio balancing occurring to reduce exposure to surprise outcomes in the forthcoming election.
mike-green
06/6/2017
10:12
not surprised to see some material profit taking...
qs99
04/5/2017
12:10
check out the web-site, may have that on it....looks like profit taking, well done all who have ridden the wave, froth coming off now placing, await next deals IMO...I'll monitor now and work out next entry position, hoping it may be below £1.20 but buyers may return before then....GLA
qs99
27/3/2017
13:31
Please can you help Who are the major share holders? Thanks bb123
bb123
22/3/2017
11:56
hxxps://www.research-tree.com/blogs/news/cello-group-profits-ahead-of-expectations
lampran
09/2/2017
16:26
great strength, hope a few have been following this, c.15% up in a week...
qs99
08/2/2017
09:52
Continued good moves....a great story really IMO given fund raise, more than required, implying more deals (+use of debt) in future, tech focus in new broker notes, share price already 10%+ above placing price as well received....more to come IMO as reckon from this share price rise, there are a few who are buying into story....DYOR and gla
qs99
08/2/2017
08:22
STILL in demand it would appear. latest broker notes have all been very positive, interesting to see one is talking about CLL being a tech play as well now with its capabilities....
qs99
06/2/2017
12:32
OK if a tech=backed model, what p/e or EV/EBITDA ratio will the market ascribe to CLL? Presume much higher than now, hence the re-rate? DYOR
qs99
06/2/2017
12:24
thanks for that. also decent yield IMO
qs99
06/2/2017
12:06
FinnCap; Post the placing, Cello has net cash and, with an acquisition, has signalled its intent to invest for growth now that the VAT issue is firmly behind it. We continue to believe Pulsar, its social media tool, is in the share price for free, but also increasingly that Cello has developed a widening range of technologies that are performing well and support good profit growth potential. Cello is moving away from an ‘hours utilised and billed' type model towards a technology-backed model, a more valuable proposition.
davebowler
01/2/2017
11:39
The oversubscribed placing underpins the share price and there is all to play for in 2017
zipstuck
01/2/2017
09:27
well that was unexpected but a nice surprise....any thoughts on this very quiet board?
qs99
19/1/2017
09:36
Price: 100.0p Target Price: 132.0p finncap.com Cello has confirmed the Group delivered an encouraging trading performance in 2016 and 2017 begins with good momentum from existing and new clients. Most importantly for our buy case, there has been an ‘excellent performance’ from Cello’s growing suite of software-enabled products. We make no changes to our forecasts and continue to believe the share price significantly undervalues the technologies Cello has developed, most notably Pulsar its social media analytics tool which we believe is in the price for free.
davebowler
04/1/2017
08:08
looks like some NY demand again, ticking up on the open
qs99
21/12/2016
12:05
bit of demand again...
qs99
08/12/2016
14:51
and some more
qs99
05/12/2016
16:03
NY until next update, but nice to see continued small steps...DYOR etc,
qs99
02/12/2016
16:18
and some more before the weekend...sir
qs99
02/12/2016
13:00
up and down like a ......showing some more life today, let's hope it can keep its northwards movement this time...
qs99
19/10/2016
13:05
showing some life again
qs99
04/10/2016
12:33
hopefully any seller now out of the way....Xd in a few days, all helps, and rising share price ...
qs99
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20171019 12:49:15